Navigation Links
Generex Provides Update on Spinout of Antigen Express
Date:9/15/2011

f over $300 million for the current status of our development program for breast cancer treatment alone.  It will also allow Generex to benefit from its controlling interest in a publicly traded Antigen Express while allowing the Company to focus on maximizing the vast opportunities for its buccal drug delivery platform."

Generex intends to issue one or more dividends of Antigen Express stock to Generex stockholders.  The record dates in respect of such dividends are yet to be determined and will be announced in due course.  The stock dividends will enable Generex stockholders to directly participate in the promising future of Antigen Express as well as create a large shareholder base that could create an environment for liquidity required by new investors.

Following the issuance of stock dividends, Generex expects to retain a controlling interest in Antigen Express, but the exact proportion of the shares to be held by Generex has not yet been determined.

Subject to market conditions and the satisfaction of regulatory requirements, it is expected that the Antigen Express spinout will occur in 2011 or early 2012.

This press release does not constitute an offer of any securities for sale or a solicitation of an offer to buy any securities.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express compris
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
2. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
3. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
4. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
5. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
6. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
7. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
8. Generex Provides Additional Details for October 21st Live Video Webcast
9. Generex Announces $3.0 Million Capital Investment
10. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
11. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Winston-Salem, NC and Rocky Mount, NC (PRWEB) September 02, ... (PMG) announced today the establishment of its 11th clinical ... 1, PMG Research has assumed ownership and operation of ... in Rocky Mount, NC, further expanding PMG’s presence in ... to an additional 130,000 patients. For the patients in ...
(Date:9/2/2014)... BETHESDA, Md. , Sept. 2, 2014  Spherix ... fostering and monetization of intellectual property, today announced that ... three patents to the Company in the month of ... of patents.  The issued patents are: ... , U.S.RE45,081 issued August 19, 2014; and ...
(Date:9/2/2014)... 2, 2014 Culot brings life ... lab management services  BioData, producer of Labguru, ... to announce the appointment of Louis Culot ... as VP Marketing and Business Development at BioDiscovery Inc., ... clinical applications. Previously, Culot worked for 17 ...
(Date:9/2/2014)... The inventors of tinAway, a novel treatment ... seeking support for development costs through a crowdfunding campaign. ... ), was launched on September 1, 2014. , tinAway ... is based on ten years of neuroscience research. ... software engineers, Dr. Ian Dixon and Mr. Tony Burgess, ...
Breaking Biology Technology:PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2Louis Culot Appointed as BioData's CEO 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 3tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 4tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 5
... reported a GAAP loss of $1.9 million, or five cents ... the company's quarterly revenues continue to rise. , ,Sonic Foundry, ... loss compares to a GAAP loss of $947,000, or three ... in the 2007 number is $395,000 in non-cash expenses for ...
... Assembly Speaker Mike Huebsch , R-West Salem, and State ... to serve on the Speaker's Task Force on Information Technology ... a number of failed information technology projects in state government, ... sectors. , ,In addition to Montgomery, who will serve as ...
... Milwaukee, Wis . - Ordinarily, the news that Wisconsin, which ... is losing one of its key venture capital firms would ... to spin off its venture capital business is being greeted ... ,The private equity firm, which has managed more than $500 ...
Cached Biology Technology:Eight lawmakers named to Speaker's IT task force 2Biotech officials praise focus of new venture fund 2Biotech officials praise focus of new venture fund 3
(Date:8/31/2014)... study, published today in Nature Climate Change , suggests ... will reach, if not exceed, the global targets for total ... authors say we should all think carefully about the food ... diets across the world is just one of a number ... climate change and ensure there is enough food for all. ...
(Date:8/29/2014)... MISSOULA Until recently, little has been known about ... An international team of scientists, one of whom is ... breakthrough by showing that genes controlling the development of ... for rabbit domestication., The study was published Aug. 28 ... genetic questions. It is online at http://www.sciencemag.org/ ., ...
(Date:8/29/2014)... release is available in German . ... signals between organisms is considered the oldest form of ... between conspecifics, for example, the sexual attraction between males ... responses and to coordinate reproductive behavior in males and ... University of the Algarve in Faro, Portugal, and at ...
Breaking Biology News(10 mins):Changing global diets is vital to reducing climate change 2Changing global diets is vital to reducing climate change 3Changing global diets is vital to reducing climate change 4New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3Ready for mating at the right time 2Ready for mating at the right time 3
... articles posted online between 10 Dec. and 21 Dec. ... America,s Geologic Time Scale. This paper marks the beginning of ... 125th Anniversary in 2013. Highlights are provided below. ... fossil record of the Gran Barranca, Patagonia, Argentina., 3. A ...
... (December 26, 2012)The Wildlife Conservation Society (WCS) announced ... across the big cat,s range due to better law ... The successes are much-needed good news as tiger ... to the combined threat of poaching, loss of prey, ...
... or nerve cells, embryonic stem cells are by definition equipped ... meaning that as an organism develops, stem cells must be ... expression programs used to turn them into blood, brain, or ... Investigator Ali Shilatifard, Ph.D., report in the December 27, 2012 ...
Cached Biology News:GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 2GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 3GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 4GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 5GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 6GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 7GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 8GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 9GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 10GSA Bulletin celebrates GSA's 125th Anniversary with new geologic time scale 11Tigers roar back: Good news for big cats in 3 key landscapes 2Tigers roar back: Good news for big cats in 3 key landscapes 3Stowers study hints that stem cells prepare for maturity much earlier than anticipated 2Stowers study hints that stem cells prepare for maturity much earlier than anticipated 3
... is for 2-D separations. The cell has a ... II xi multi-cell can be customized for several ... and cooling system. The PROTEAN II xi multi-cell ... XL multi-cell for a wider format that accommodates ...
... depletion cocktail is tailored to ... suspensions of rat spleen cells. ... StemSep (or compatible 0.5 Tesla) ... T cell content of the ...
... 20 cm, is used for vertical slab gel ... gels. The cell is supplied without spacers and ... with gaskets, lower buffer chamber, lid with cables, ... upper buffer dam, casting stand with gaskets, leveling ...
...
Biology Products: